Vanda Pharmaceuticals | Ventes



Sales Changement Date
Acadia Pharmaceuticals USD 244.32M 15.28M 2025-03
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Arrowhead Research USD 542.71M 540.21M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Halozyme Therapeutics USD 265M 33.01M 2025-03
Insmed USD 92.82M 11.62M 2025-03
J&J USD 21.89B 630M 2025-03
Ligand Pharmaceuticals USD 45.33M 2.52M 2025-03
Merck USD 15.53B 94M 2025-03
Moderna USD 108M 858M 2025-03
Novartis USD 13.56B 386M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
PTC Therapeutics USD 190M 23.17M 2025-03
Sanofi EUR 9.9B 660M 2025-03
Takeda JPY 1.05T 90B 2025-03
Teva Pharmaceutical Industries USD 14.06B 1.27B 2025-03
Ultragenyx Pharmaceutical USD 139.29M 25.59M 2025-03
Veracyte USD 114.47M 4.13M 2025-03



Vanda Pharmaceuticals Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.